Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q2 FY22 Earnings Presentation
17 slides from Rossari Biotech's earnings presentation, Oct 30, 2021
Slide 1: Rossari – Q2 FY22 Earnings Presentation Cover Letter
ROSSARI making you more competitive October 30, 2021 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No.C/1, 'G'Block, Bandra- Kurla Complex Dalal Street, Fort Mumbai 4
Slide 2: Rossari Biotech Limited Q2 & H1 FY22 Results Presentation
® ROSSARI making you mor,e·competitive Rossari Biotech Limited Q2 & H1 FY22 Results Presentation October 30, 2021
Slide 3: Disclaimer
® Disclaimer ROSSARI making you more competitive Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticip
Slide 4: Q2 & H1 FY22 Results Overview
ROSSARI making you more competi tive Q2 & H1 FY22 Results Overview 3
Slide 5: Q2 FY22 – Key Financial Highlights
Q2 FY22 – Key Financial Highlights ® ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 26.2 44.0 24.5 384.5 37.1 20.7* 30.1 231.1 171.7 Q1 FY22 Q2 FY21 Q2 FY22 Q1 FY22 Q2 FY21 Q2 FY22 Q1 FY22 Q2 FY21 Q2 FY22 Shift % (Y-o-Y) 123.93% 46.17% 26.5
Slide 6: Management Message
Management Message ROSSARI making you more competitive Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We have reported a healthy topline performance led by increased client engagements a
Slide 7: Key Developments
Key Developments ® ROSSARI making you more competitive Successfully integrated recently acquired companies - Unitop and Tristar • In June & July 2021, the Board of Directors of Rossari approved the acquisition of Unitop Chemicals and Tristar Intermediates, respectively • Rossari has successfully int
Slide 8: Key Developments
Key Developments ® ROSSARI making you more competitive The Board of Directors appoint Mr. Debashish Vanikar as Chief Executive Officer (CEO) - New Businesses • Mr. Debashish Vanikar has been appointed as CEO - New Businesses with effect from November 19, 2021 • Mr. Vanikar has over 21 years of rich
Slide 9: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated ® ROSSARI making you more competitive Y-o-Y Change Y-o-Y Change Particulars (Rs. crore) Q2 FY22 Q2 FY21 H1 FY22 H1 FY21 (%) (%) Revenues from Operations 384.5 171.7 123.9% 615.6 281.1 119.0% Total Expenditure • COGS 299.2 108.1 176.8% 459.1 171.8 167.2% • Employ
Slide 10: Consolidated Balance Sheet
Consolidated Balance Sheet ® ROSSARI making you more competitive EQUITY AND LIABILITIES CONSOLIDATED CONSOLIDATED ASSETS CONSOLIDATED CONSOLIDATED As on 30th Sept 2021 As on 31st March 2021 As on 30th Sept 2021 As on 31st March 2021 Particulars (Rs. crore) Particulars (Rs. crore) (Un-Audited) (Audit
Slide 11: Consolidated Cash Flows
® Consolidated Cash Flows ROSSARI making you more competitive CASH FLOW CONSOLIDATED CONSOLIDATED CASH FLOW CONSOLIDATED CONSOLIDATED As on 30th Sept 2021 As on 31st March 2021 As on 30th Sept 2021 As on 31st March 2021 Particulars (Rs. crore) Particulars (Rs. crore) (Un-Audited) (Audited) (Un-Audit
Slide 12: Q2 FY22 - Segment-wise Details
Q2 FY22 - Segment-wise Details ® ROSSARI making you more competitive Segment-wise Revenue Break-up (Rs. crore) ■ Q2 FY21 ■ Q1 FY22 ■ Q2 FY22 236.1 132.3 109.7 87.7 74.7 68.3 24.1 38.7 15.6 HPPC TSC AHN Shift (Y-o-Y) % 169.2% 60.6% 148.1% Shift (Q-o-Q) % 78.4% 46.9% 60.6% Key Highlights: HPPC, TSC
Slide 13: Q2 FY22 - Financial and Operational Discussions (Y-o-Y)
Q2 FY22 - Financial and Operational Discussions (Y-o-Y) ® ROSSARI making you more competitive Net Revenues Q2 FY22 Revenues from operations stood at Rs. 384.5 crore, higher by 124.1% YoY Robust growth witnessed across businesses HPPC delivered strong sales supported by healthy traction in FMCG a
Slide 14: Annexure
® ROSSARI making you more competitive Annexure 13
Slide 15: Conference Call Details
Conference Call Details Q2 & H1 FY22 Earnings Conference Call Time • 5:30 p.m. IST on Monday, November 1, 2021 To enable participants to connect to the conference call without Pre-registration having to wait for an operator, please register at the below mentioned link: Primary dial-in number • + 91
Slide 16: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a For further information, please contact: Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Manasi Nisal Headquartered at Mumbai, India, the Company operates 2
Slide 17: Thank You
® ROSSARI making you more competitive Thanky•u 16